C. Lorenzo

The response of the mental health network of the Salamanca area to the COVID-19 pandemic: The role of the telemedicine.

C. Roncero, A. Montejo, Javier Pérez, 2020, Psychiatry Research.

PGPM_A_320816 1015..1025

E. Marcos-Vadillo, M. Ángel, M. Isidoro-García, 2021 .

Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy

A. Gaedigk, E. Marcos-Vadillo, M. Isidoro-García, 2022, Pharmaceutics.

Application of a Pharmacogenetics-Based Precision Medicine Model (5SPM) to Psychotic Patients That Presented Poor Response to Neuroleptic Therapy

E. Marcos-Vadillo, M. Franco-Martín, M. Isidoro-García, 2020, Journal of personalized medicine.

Pharmacogenetics to prevent maniac affective switching with treatment for bipolar disorder: CYP2D6.

A. Gaedigk, M. Isidoro-García, C. Lorenzo, 2016, Pharmacogenomics.

PRIORITIZING PSYCHOSOCIAL REHABILITATION AND USERS RIGHTS: THE COMMUNITY MENTAL HEALTH APPROACH IN EGYPT

E. Materia, K. Saeed, A. Gaddini, 2014 .

Economic Impact of the Application of a Precision Medicine Model (5SPM) on Psychotic Patients

E. Marcos-Vadillo, M. Isidoro-García, Lorena Carrascal-Laso, 2021, Pharmacogenomics and personalized medicine.

Tardive Dyskinesia After Aripiprazole Treatment That Improved With Tetrabenazine, Clozapine, and Botulinum Toxin

C. Roncero, A. Montejo, L. Aguilar, 2019, Front. Pharmacol..